Together, these three pathways create a more comprehensive metabolic shift than any single or dual agonist can achieve
Primary Respondent Breakdown: By Designation: C-level Primaries (29%), Director Level (34%), Others (37%) By Region: North America (32%), Europe (29%), Asia-Pacific (28%), Rest of World (11%) Market Size Estimation Global market valuation was derived through revenue mapping and prescription volume analysis
It has several effects that are helpful in the treatment of T2DM: it lowers glucose production in the liver, it sensitizes tissues to insulin, and it promotes weight loss
Tirzepatide (GLP-1 + GIP): This is a newer, dual-action medication and the same active ingredient as Mounjaro and Zepbound
Over time, it can cause irreversible nerve damage, cognitive decline, and mental health disorders such as depression